Rabehue Tablet 10mg (Rabeprazole Sodium)

Adult dose

For gastric ulcer and duodenal ulcer: Take 10 mg orally once daily. Depending on symptoms, 20 mg may be taken orally once daily. For erosive or ulcerative gastroesophageal reflux disease: 10 mg or 20 mg taken orally once daily for 4 to 8 weeks. If not resolved after 8 weeks of proton pump inhibitor therapy, an additional 8 weeks of 10 mg or 20 mg may be taken orally twice daily.

This drug should not be used in patients with allergies to certain medications or components. Women who are pregnant or breastfeeding should also avoid using this drug. Patients with impaired liver function or the elderly should use this drug with caution, and individuals with a history of allergies should also use it carefully. If allergic reactions such as skin rash or itching occur while taking this medication, discontinue use immediately. It is important to regularly undergo blood tests and liver function tests to check for abnormalities. Symptoms related to the heart or vascular system may occur, so if symptoms appear, consult a medical professional. Mental symptoms, neurological abnormalities, and respiratory symptoms may also occur, so caution is required. Long-term use may increase the risk of bone fractures and lead to electrolyte imbalances such as hypomagnesemia, hence regular monitoring is necessary. This drug strongly inhibits gastric acid secretion, which may slightly increase the risk of bacterial infections in the stomach. Caution is needed as drowsiness or dizziness may occur when driving or operating machinery. Since this drug may interact with other medications, inform your healthcare provider about any other medications you are taking. Do not chew or crush this drug; swallow it whole, and keep it out of the reach of children. There is no specific antidote for overdose; treatment should be symptomatic. Long-term use may result in impaired absorption of vitamin B12, so regular monitoring is required. If symptoms of autoimmune diseases such as systemic lupus erythematosus appear while taking this drug, discontinue use immediately and consult with a specialist. It is recommended to discontinue this medication at least 14 days prior to measuring serum chromogranin A levels for testing.

Serious side effects

Hives, severe allergic reactions (such as hypotension, shortness of breath, facial swelling, etc.), fulminant hepatitis, liver dysfunction, jaundice, difficulty breathing, asthma attacks, breathing difficulties accompanied by pulmonary findings, interstitial pneumonia, adverse reactions on skin and mucous membranes (such as toxic epidermal necrolysis (Lyell syndrome), mucocutaneous syndrome (Stevens-Johnson syndrome), erythema multiforme), acute interstitial nephritis, serious neurological symptoms (such as seizures, coma, disorientation, confusion, etc.)

Mild side effects

Occasionally, rash, itching, blood disorders (such as erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, etc.), increases in ALT, AST, ALP, γ-GTP, LDH, total bilirubin, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, degree block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, and heart.

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x 2)